Unknown

Dataset Information

0

Phosphorylation-Assisted Luciferase Complementation Assay Designed to Monitor Kinase Activity and Kinase-Domain-Mediated Protein-Protein Binding.


ABSTRACT: Protein kinases are key regulators of cell signaling and have been important therapeutic targets for three decades. ATP-competitive drugs directly inhibit the activity of kinases but these enzymes work as part of complex protein networks in which protein-protein interactions (often referred to as kinase docking) may govern a more complex activation pattern. Kinase docking is indispensable for many signaling disease-relevant Ser/Thr kinases and it is mediated by a dedicated surface groove on the kinase domain which is distinct from the substrate-binding pocket. Thus, interfering with kinase docking provides an alternative strategy to control kinases. We describe activity sensors developed for p90 ribosomal S6 kinase (RSK) and mitogen-activated protein kinases (MAPKs: ERK, p38, and JNK) whose substrate phosphorylation is known to depend on kinase-docking-groove-mediated protein-protein binding. The in vitro assays were based on fragment complementation of the NanoBit luciferase, which is facilitated upon substrate motif phosphorylation. The new phosphorylation-assisted luciferase complementation (PhALC) sensors are highly selective and the PhALC assay is a useful tool for the quantitative analysis of kinase activity or kinase docking, and even for high-throughput screening of academic compound collections.

SUBMITTER: Poti AL 

PROVIDER: S-EPMC10573712 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Phosphorylation-Assisted Luciferase Complementation Assay Designed to Monitor Kinase Activity and Kinase-Domain-Mediated Protein-Protein Binding.

Póti Ádám L ÁL   Dénes Laura L   Papp Kinga K   Bató Csaba C   Bánóczi Zoltán Z   Reményi Attila A   Alexa Anita A  

International journal of molecular sciences 20231003 19


Protein kinases are key regulators of cell signaling and have been important therapeutic targets for three decades. ATP-competitive drugs directly inhibit the activity of kinases but these enzymes work as part of complex protein networks in which protein-protein interactions (often referred to as kinase docking) may govern a more complex activation pattern. Kinase docking is indispensable for many signaling disease-relevant Ser/Thr kinases and it is mediated by a dedicated surface groove on the  ...[more]

Similar Datasets

| S-EPMC6225193 | biostudies-literature
| S-EPMC3626928 | biostudies-literature
| S-EPMC10119766 | biostudies-literature
| S-EPMC5340998 | biostudies-literature
| S-EPMC8678545 | biostudies-literature
| S-EPMC7446724 | biostudies-literature
| S-EPMC2922018 | biostudies-literature
2016-12-22 | PXD003944 | Pride
| S-EPMC6256781 | biostudies-literature
| S-EPMC4077619 | biostudies-literature